Frontiers in Cellular and Infection Microbiology (Nov 2022)

The emerging role of DEAD/H-box helicases in hepatitis B virus infection

  • Hongjuan You,
  • Lihong Ma,
  • Xing Wang,
  • Fulong Zhang,
  • Yiran Han,
  • Jiaqi Yao,
  • Xiucheng Pan,
  • Kuiyang Zheng,
  • Kuiyang Zheng,
  • Fanyun Kong,
  • Renxian Tang,
  • Renxian Tang

DOI
https://doi.org/10.3389/fcimb.2022.1062553
Journal volume & issue
Vol. 12

Abstract

Read online

DEAD/H-box helicases are an essential protein family with a conserved motif containing unique amino acid sequences (Asp-Glu-Ala-Asp/His). Current evidence indicates that DEAD/H-box helicases regulate RNA metabolism and innate immune responses. In recent years, DEAD/H-box helicases have been reported to participate in the development of a variety of diseases, including hepatitis B virus (HBV) infection, which is a significant risk factor for hepatic fibrosis, cirrhosis, and liver cancer. Furthermore, emerging evidence suggests that different DEAD/H-box helicases play vital roles in the regulation of viral replication, based on the interaction of DEAD/H-box helicases with HBV and the modulation of innate signaling pathways mediated by DEAD/H-box helicases. Besides these, HBV can alter the expression and activity of DEAD/H-box helicases to facilitate its biosynthesis. More importantly, current investigation suggests that targeting DEAD/H-box helicases with appropriate compounds is an attractive treatment strategy for the virus infection. In this review, we delineate recent advances in molecular mechanisms relevant to the interplay of DEAD/H-box helicase and HBV and the potential of targeting DEAD/H-box helicase to eliminate HBV infection.

Keywords